On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators.
D000081:Acetamides / Q000037:antagonists & inhibitors; D000241:Adenosine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000818:Animals; D001783:Blood Flow Velocity; D002110:Caffeine / Q000494:pharmacology; D002463:Cell Membrane Permeability; D003331:Coronary Vessels / Q000187:drug effects; D003374:Coumarins / Q000037:antagonists & inhibitors; D004176:Dipyridamole / Q000037:antagonists & inhibitors; D004285:Dogs; D004347:Drug Interactions; D004912:Erythrocytes; D005260:Female; D006016:Glycolates / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D010879:Piperazines / Q000037:antagonists & inhibitors; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors*; D014970:Xanthines / Q000494:pharmacology*; D014992:Xylenes / Q000037:antagonists & inhibitors
D000081:Acetamides; D003374:Coumarins; D006016:Glycolates; D010879:Piperazines; D011955:Receptors, Drug; D014665:Vasodilator Agents; D014970:Xanthines; D014992:Xylenes; D002110:Caffeine; D004176:Dipyridamole; D013806:Theophylline; D000241:Adenosine